OSCR
Oscar Health·NYSE
--
--(--)
--
--(--)
4.87 / 10
Netural
Fund flow analysis scores 7.83/10, indicating robust liquidity momentum; small-cap inflows are positive (0.50), while block and larger orders are negative. This divergence suggests institutional hesitation despite retail interest. Analyst coverage is neutral (100% of two providers), with historical win rates ranging from 33% to 50%, reflecting low conviction. The market expectation is pessimistic, aligning with the current price decline (-13.29%). Together, the analyst and fund flow data reinforce a wait-and-see stance until clearer signals emerge.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-05
InstitutionBarclays
Times predicted4
Historical Win Rate50.0%
What is the analyst consensus for OSCR?
- OSCR holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.87/10 (Netural).
